Teva Presents New Phase 3 Efficacy, Safety and Tolerability Data from SOLARIS Trial Evaluating TEV-‘749 (olanzapine) as a Once-Monthly Subcutaneous Long-Acting Injectable for Adult Patients Diagnosed with Schizophrenia 21-09-2024, 15:15

Cathay Cargo Leveraged Descartes Air Cargo Tracking Solution to Help Support Safe Journey of Giant Pandas 16-10-2024, 17:45

C.K. McWhorter Announces Next Steps Into Sustainable Luxury and Global Philanthropic Impact 8-02-2024, 02:23